Amwell® Announces Results for First Quarter 2026
Rhea-AI Summary
Amwell (NYSE: AMWL) announced financial results for the first quarter ended March 31, 2026, and will host a conference call today at 5:00 p.m. ET. The earnings report and a live audio webcast are available at the company's investor site; a replay will be available for about 90 days.
Positive
- None.
Negative
- None.
News Market Reaction – AMWL
In the May 6 session, AMWL gained 12.42%, reflecting a significant positive market reaction. Argus tracked a peak move of +15.9% during that session. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 12 | Q4/FY25 earnings | Neutral | +24.7% | Reported Q4 and full-year 2025 results with 5 p.m. ET conference call. |
| Nov 04 | Q3 2025 earnings | Neutral | -9.5% | Announced Q3 2025 results and scheduled same-day 5 p.m. ET call. |
| Aug 05 | Q2 2025 earnings | Neutral | -7.3% | Released Q2 2025 results with investor webcast and 90-day replay. |
| May 01 | Q1 2025 earnings | Neutral | +19.7% | Announced Q1 2025 results and hosted 5 p.m. ET conference call. |
| Feb 12 | Q4/FY24 earnings | Neutral | -5.0% | Reported Q4 and full-year 2024 results with webcasted investor call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings releases have produced mixed reactions, with both strong rallies and notable selloffs around prior quarterly results.
Over the past year, Amwell has followed a consistent pattern of announcing quarterly and annual results with an associated 5 p.m. ET conference call and ~90-day webcast replay. Prior earnings-related moves ranged from a +24.71% jump after Q4/FY 2025 results on Feb 12, 2026 to declines of -9.5% and -7.31% after Q3 and Q2 2025 results. The current Q1 2026 announcement fits this cadence of regular financial disclosures and post-close calls.
Key Terms
saas-based technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the first quarter ended March 31, 2026. The company’s first quarter earnings report can be viewed at investors.amwell.com.
Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/b826q95x/. A webcast replay will be available for approximately 90 days at investors.amwell.com.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Contacts
Media:
press@amwell.com
Investors:
Asher Dewhurst
amwell@icrhealthcare.com
